Clinical Trial: Microbiome-Based Risk Prediction of SARS-CoV-2 in Children and Families (PREDICOL)

U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07717008) titled 'Microbiome-Based Risk Prediction of SARS-CoV-2 in Children and Families (PREDICOL)' on Jan. 15.

Brief Summary: The goal of this observational cohort study is to evaluate the association between gut microbiota composition, dietary patterns, lifestyle-related factors, and neurodevelopmental outcomes, as well as susceptibility to SARS-CoV-2 infection, in a predominantly school-aged population and their adult contacts (family and teachers).

This study aims to answer the following main questions:

* Are specific gut microbiota profiles and dietary patterns associated with cognitive and behavioral development in non-clinical children and...